Search results
Results from the WOW.Com Content Network
The "Draper Double Bounce" sparked some controversy Friday as an apparent missed call ended Felix Auger-Aliassime's run in the Cincinnati Open
Defending champion Félix Auger-Aliassime [1] defeated Hubert Hurkacz in the final, 7–6 (7–3), 7–6 (7–5) to win the singles tennis title at the 2023 Swiss Indoors. He saved a match point en route to his fifth career ATP Tour title (and his first in a year), in the quarterfinals against Alexander Shevchenko.
Félix Auger-Aliassime (French pronunciation: [feliks oʒe aljasim]; [6] born August 8, 2000) is a Canadian professional tennis player. He has a career-high singles ranking of No. 6, which he achieved on November 7, 2022, making him the second-highest-ranked Canadian man in ATP rankings history and the fourth-highest-ranked Canadian player in history. [7]
Félix Auger-Aliassime defeated Sebastian Korda in the final, 6–3, 3–6, 6–1 to win the men's singles tennis title at the 2025 Adelaide International. It was his sixth ATP Tour singles title and his first outside of indoor hardcourts.
TOKYO (AP) — Felix Auger-Aliassime defeated Sebastian Ofner 6-4, 6-1 to advance to the quarterfinals of the Japan Open on Wednesday, winning consecutive matches for the first time since March.
Andrey Rublev defeated Félix Auger-Aliassime in the final, 4–6, 7–5, 7–5 to win the men's singles tennis title at the 2024 Madrid Open. It was his second Masters 1000 and 16th career ATP Tour singles title.
Second round lost to Félix Auger-Aliassime: 8 9 Grigor Dimitrov: 3,690 (45) † 10 3,655: Second round lost to Fábián Marozsán: 9 11 Stefanos Tsitsipas: 3,465 90 50 3,425: Second round lost to Jack Draper: 10 13 Tommy Paul: 3,065 90 10 2,985: First round lost to Flavio Cobolli: 11 12 Taylor Fritz: 3,290 180 10 3,120: First round lost to ...
Félix Auger-Aliassime defeated Sebastian Korda in the final, 6–3, 6–4 to win the singles tennis title at the 2022 European Open. It was his second title in as many weeks and third career ATP Tour singles title overall.